Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment
Azadeh Hekmat,
Luciano Saso,
Viney Lather,
Deepti Pandita,
Irena Kostova,
Ali Akbar Saboury
Affiliations
Azadeh Hekmat
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran
Luciano Saso
Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University, I-00185 Rome, Italy
Viney Lather
Amity Institute of Pharmacy, Amity University, Noida 201313, Uttar Pradesh, India
Deepti Pandita
Department of Pharmaceutics, Delhi Institute of Pharmaceutical Sciences & Research (DIPSAR) Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, Government of NCT of Delhi, New Delhi 110017, India
Irena Kostova
Department of Chemistry, Faculty of Pharmacy, Medical University, 2 Dunav St., 1000 Sofia, Bulgaria
Ali Akbar Saboury
Institute of Biochemistry and Biophysics, University of Tehran, Tehran 1417466191, Iran
Breast cancer is one of the most common malignancies and a leading cause of cancer-related mortality among women worldwide. The elements of group XIV in the periodic table exhibit a wide range of chemical manners. Recently, there have been remarkable developments in the field of nanobiomedical research, especially in the application of engineered nanomaterials in biomedical applications. In this review, we concentrate on the recent investigations on the antiproliferative effects of nanomaterials of the elements of group XIV in the periodic table on breast cancer cells. In this review, the data available on nanomaterials of group XIV for breast cancer treatment has been documented, providing a useful insight into tumor biology and nano–bio interactions to develop more effective nanotherapeutics for cancer patients.
